Kryxana 200 mg Tablet 21's belongs to the group of anti-cancer medicines called cyclin-dependent kinase (CDK) inhibitors used to treat a type of breast cancer that is locally advanced or metastatic (has spread to other parts of the body). Breast cancer is a type of cancer that develops in the breast when the breast cells begin to grow abnormally.
Kryxana 200 mg Tablet 21's contains ‘Ribociclib’, which works by blocking cyclin-dependent kinase 4 and 6 proteins, which are necessary for the growth and division of the cells. Thereby, slows down the growth of cancer cells and delays the progression of cancer.
You are advised to take Kryxana 200 mg Tablet 21's for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as diarrhoea, nausea, vomiting, constipation, hair loss, fatigue, dizziness, back pain, and headache. Do not be reluctant to talk with your doctor if you experience any of these side effects persistently.
Avoid taking Kryxana 200 mg Tablet 21's if you are pregnant or breastfeeding. Kryxana 200 mg Tablet 21's may cause tiredness and dizziness, so drive only if you are alert. Kryxana 200 mg Tablet 21's should not be given to children as safety and effectiveness have not been established. Avoid consuming alcohol with Kryxana 200 mg Tablet 21's as it could lead to increased dizziness. Inform your doctor about your health condition and medications to rule out any side effects/interactions.